Fig. 1: Both high serum cf-QSOX1 and tumorous QSOX1 levels correlate with better prognosis of patients with HCC. | Cell Death Discovery

Fig. 1: Both high serum cf-QSOX1 and tumorous QSOX1 levels correlate with better prognosis of patients with HCC.

From: Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma

Fig. 1

a The serum glycoproteins from patients of set C were enriched by LCA lectin affinity chromatography followed by Western blot against QSOX1. Serum cf-QSOX1 levels in HCC recurrence (n = 28) and HCC non-recurrence group (n = 32) were compared. b Kaplan–Meier curves for time to recurrence (TTR) in HCC patients of set C according to serum cf-QSOX1 level. The median expression level of serum cf-QSOX1 was used as the cutoff value. c Receiver operating characteristic (ROC) analysis for serum cf-QSOX1. d–f Sections for representative type I staining and type II staining and negative staining of QSOX1 in tumor tissues are shown (bar, 100 μm). Kaplan–Meier curves show the overall survival (g) and time to recurrence (h) in HCC patients from cohort B according to tumorous QSOX1 densities. The median QSOX1 density was used as the cutoff for the definition of subgroups. Values are expressed as the mean ± SD

Back to article page